Filing Details
- Accession Number:
- 0001493152-17-011127
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-10-02 12:54:25
- Reporting Period:
- 2017-09-29
- Accepted Time:
- 2017-10-02 12:54:25
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 868278 | Prophase Labs Inc. | PRPH | Pharmaceutical Preparations (2834) | 232577138 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1142043 | Jr V Robert Cuddihy | 621 N. Shady Retreat Road Doylestown PA 18901 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.005 | Disposition | 2017-09-29 | 358,621 | $2.30 | 132,703 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- These shares were sold to the Issuer through the tender offer by the Issuer for 4,000,000 shares of its common stock.
Billionaire Hedge Funds
